SCHEMBL2639146

SCHEMBL2639146

CC=Cc1c(O)cc(OC)cc1O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ERN1 O75460 1/20 0.53
▸ CYP3A4 P08684 3/20 0.52
▸ CYP1A1 P04798 5/20 0.46
▸ CYP1B1 Q16678 5/20 0.46
▸ KDM4E B2RXH2 4/20 0.46
▸ ABL1 P00519 4/20 0.46
▸ BCR P11274 4/20 0.46
▸ ALOX5 P09917 3/20 0.46
▸ PTGS2 P35354 3/20 0.46
▸ TTR P02766 2/20 0.46
▸ MEN1 O00255 2/20 0.46
▸ MAPT P10636 2/20 0.46
▸ KMT2A Q03164 2/20 0.46
▸ PTGS1 P23219 2/20 0.46
▸ ABCB1 P08183 2/20 0.46
▸ NPC1 O15118 1/20 0.46
▸ GAA P10253 1/20 0.46
▸ NQO2 P16083 1/20 0.46
▸ MAPK1 P28482 1/20 0.46
▸ RAB9A P51151 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
4-Vinylphenol SCHEMBL5900826 0.83 ALOX5 (0.53) ERN1CYP3A4CYP1A1CYP1B1KDM4E
SCHEMBL9742123 0.81 CNR2 (0.41) CYP3A4CYP1A1CYP1B1KDM4EALOX5
SCHEMBL9742118 0.81 CNR2 (0.41) CYP3A4CYP1A1CYP1B1KDM4EALOX5
SCHEMBL9605433 0.77 CYP1A1 (0.67) CYP3A4CYP1A1CYP1B1KDM4EABL1
SCHEMBL7031594 0.76 ERN1 (0.78) ERN1CYP3A4CYP1A1CYP1B1KDM4E
SCHEMBL10603021 0.76 CYP1A1 (0.58) ERN1CYP3A4CYP1A1CYP1B1KDM4E
SCHEMBL7868949 0.76 CYP1A1 (0.58) ERN1CYP3A4CYP1A1CYP1B1KDM4E
SCHEMBL13802132 0.74 CYP1A1 (0.67) ERN1CYP3A4CYP1A1CYP1B1KDM4E
SCHEMBL67338 0.71 CYP3A4 (0.67) ERN1CYP3A4CYP1A1CYP1B1KDM4E
SCHEMBL9551490 0.70 CYP3A4 (0.58) ERN1CYP3A4CYP1A1CYP1B1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4791042-B2 — — 2011-10-12 — — JP claimed
EP-1401562-B1 PROCESS FOR THE FORMATION OF EMULSIONS SYNGENTA LTD (GB) 2008-10-08 — — EP claimed
CN-100415354-C Use of reactive polymeric surfactants in formation of emulsions SYNGENTA LTD (GB) 2008-09-03 — — CN claimed
US-7199185-B2 Use of reactive polymeric surfactants in the formation of emulsions SYNGENTA LIMITED (GB) 2007-04-03 — — US claimed
EP-1569512-B1 PARTICULATE SUSPENSIONS SYNGENTA LTD (GB) 2007-02-28 — — EP claimed
US-20060116290-A1 Particulate suspensions SYNGENTA CROP PROTECTION, INC. 2006-06-01 — — US claimed
EP-1569512-A2 PARTICULATE SUSPENSIONS Syngenta Limited (GB) 2005-09-07 — — EP claimed
CN-1541136-A Use of reactive polymeric surfactants in emulsion formation — 2004-10-27 — — CN claimed
US-20040197357-A1 Use of reactive polymeric surfactants in the formation of emulsions SYNGENTA LIMITED (GB) 2004-10-07 — — US claimed
WO-2004052099-A2 PARTICULATE SUSPENSIONS SYNGENTA LIMITED (GB) 2004-06-24 — — WO claimed
EP-1401562-A2 USE OF REACTIVE POLYMERIC SURFACTANTS IN THE FORMATION OF EMULSIONS Syngenta Limited (GB) 2004-03-31 — — EP claimed
WO-2002100525-A2 USE OF REACTIVE POLYMERIC SURFACTANTS IN THE FORMATION OF EMULSIONS SYNGENTA LIMITED (GB) 2002-12-19 — — WO claimed
EP-1401562-B1 PROCESS FOR THE FORMATION OF EMULSIONS SYNGENTA LTD (GB) 2008-10-08 — — EP disclosed
CN-100415354-C Use of reactive polymeric surfactants in formation of emulsions SYNGENTA LTD (GB) 2008-09-03 — — CN disclosed
US-7199185-B2 Use of reactive polymeric surfactants in the formation of emulsions SYNGENTA LIMITED (GB) 2007-04-03 — — US disclosed
EP-1569512-B1 PARTICULATE SUSPENSIONS SYNGENTA LTD (GB) 2007-02-28 — — EP disclosed
US-20040197357-A1 Use of reactive polymeric surfactants in the formation of emulsions SYNGENTA LIMITED (GB) 2004-10-07 — — US disclosed
WO-2004052099-A2 PARTICULATE SUSPENSIONS SYNGENTA LIMITED (GB) 2004-06-24 — — WO disclosed
EP-1401562-A2 USE OF REACTIVE POLYMERIC SURFACTANTS IN THE FORMATION OF EMULSIONS Syngenta Limited (GB) 2004-03-31 — — EP disclosed
WO-2002100525-A2 USE OF REACTIVE POLYMERIC SURFACTANTS IN THE FORMATION OF EMULSIONS SYNGENTA LIMITED (GB) 2002-12-19 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040197357-A1 Use of reactive polymeric surfactants in the formation of emulsions PHOSPHO1, APOB, LIPA ERN1 2936/4885CYP3A4 4114/4885CYP1A1 3482/4885
US-20060116290-A1 Particulate suspensions PFAS, VCL, JMJD7 ERN1 3399/4885CYP3A4 498/4885CYP1A1 57/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback